Who is sponsoring NCT01143714?

NCT01143714 is sponsored by Healthpoint.

What condition does NCT01143714 study?

NCT01143714 studies Diabetic Foot Ulcers.

What drugs are being tested in NCT01143714?

Interventions: Santyl, White Petrolatum.

What is the status of NCT01143714?

NCT01143714 is currently COMPLETED.

Last reviewed 2013-05-02 · How we verify

A Vehicle-Controlled Study to Determine the Effect of Four Weeks of Debridement With Collagenase Santyl Ointment (Santyl) on the Healing of Diabetic Foot Ulcers

NCT01143714 Phase 4 COMPLETED Results posted

The purpose of this study is to assess the effect of four weeks of treatment with Santyl Ointment, compared to White Petrolatum, on the change from baseline in wound area of diabetic foot ulcers over four weeks, and on the proportion of subjects achieving complete wound closure within 12 weeks from initiation of treatment.

Details

Lead sponsor	Healthpoint
Phase	Phase 4
Status	COMPLETED
Enrolment	57
Start date	2010-06
Completion	2012-10

Conditions

Diabetic Foot Ulcers

Interventions

Santyl
White Petrolatum

Primary outcomes

Change in Wound Area — 4 Weeks
The primary efficacy endpoint was the percent change in wound area from baseline to completion of the 4-week treatment phase and the 8-week follow-up period

Countries

United States